SAN FRANCISCO–(BUSINESS WIRE)– #MultiplyLabs–Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA’s open Isaac and GR00T technologies including advanced robotics simulation and perception, marking a turning point for an industry that has historically relied on manual, “artisanal” processes. Cell and gene therapies are life-changing treatments that hold the potential to add
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/multiply-labs-to-bring-physical-ai-robotics-technology-to-advanced-biomanufacturing-with-nvidia-2/
